Molecular insights into substrate recognition and catalysis by tryptophan 2,3-dioxygenase

被引:154
|
作者
Forouhar, Farhad
Anderson, J. L. Ross
Mowat, Christopher G.
Vorobiev, Sergey M.
Hussain, Arif
Abashidze, Mariam
Bruckmann, Chiara
Thackray, Sarah J.
Seetharaman, Jayaraman
Tucker, Todd
Xiao, Rong
Ma, Li-Chung
Zhao, Li
Acton, Thomas B.
Montelione, Gaetano T.
Chapman, Stephen K.
Tong, Liang [1 ]
机构
[1] Columbia Univ, NE Struct Genom Consortium, New York, NY 10027 USA
[2] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland
[3] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA
[4] Rutgers State Univ, NE Struct Genom Consortium, Piscataway, NJ 08854 USA
关键词
cancer; heme enzymes; immunomodulation; indoleamine 2,3-dioxygenase;
D O I
10.1073/pnas.0610007104
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tryptophan 2,3-dioxygenase (TDO) and indoleamine 2,3-dioxygenase (IDO) constitute an important, yet relatively poorly understood, family of heme-containing enzymes. Here, we report extensive structural and biochemical studies of the Xanthomonas campestris TOO and a related protein SO4414 from Shewanella oneidensis, including the structure at 1.6-angstrom resolution of the catalytically active, ferrous form of TOO in a binary complex with the substrate L-Trp. The carboxylate and ammonium moieties of tryptophan are recognized by electrostatic and hydrogen-bonding interactions with the enzyme and a propionate group of the heme, thus defining the L-stereospecificity. A second, possibly allosteric, L-Trp-binding site is present at the tetramer interface. The sixth coordination site of the heme-iron is vacant, providing a dioxygen-binding site that would also involve interactions with the ammonium moiety Of L-Trp and the amide nitrogen of a glycine residue. The indole ring is positioned correctly for oxygenation at the C2 and C3 atoms. The active site is fully formed only in the binary complex, and biochemical experiments confirm this induced-fit behavior of the enzyme. The active site is completely devoid of water during catalysis, which is supported by our electrochemical studies showing significant stabilization of the enzyme upon substrate binding.
引用
收藏
页码:473 / 478
页数:6
相关论文
共 50 条
  • [31] New Inhibitors of Indoleamine 2,3-Dioxygenase 1: Molecular Modeling Studies, Synthesis, and Biological Evaluation
    Coluccia, Antonio
    Passacantilli, Sara
    Famiglini, Valeria
    Sabatino, Manuela
    Patsilinakos, Alexandros
    Ragno, Rino
    Mazzoccoli, Carmela
    Sisinni, Lorenza
    Okuno, Alato
    Takikawa, Osamu
    Silvestri, Romano
    La Regina, Giuseppe
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (21) : 9760 - 9773
  • [32] Tryptophan 2,3-Dioxygenase (TDO) Inhibitors. 3-(2-(Pyridyl)ethenyl)indoles as Potential Anticancer Immunomodulators
    Dolusic, Eduard
    Larrieu, Pierre
    Moineaux, Laurence
    Stroobant, Vincent
    Pilotte, Luc
    Colau, Didier
    Pochet, Lionel
    Van den Eynde, Benoit
    Masereel, Bernard
    Wouters, Johan
    Frederick, Raphael
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (15) : 5320 - 5334
  • [33] Emerging Concepts on Inhibitors of Indoleamine 2,3-Dioxygenase in Rheumatic Diseases
    Filippini, P.
    Del Papa, N.
    Sambataro, D.
    Del Bufalo, A.
    Locatelli, F.
    Rutella, S.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (31) : 5381 - 5393
  • [34] Evaluation of Indoleamine 2,3-Dioxygenase (IDO) Expression in Osteosarcoma: Insights From a 10-Year Retrospective Cohort
    Farooq, Asim
    Amin, Aatif
    Bashir, Shaarif
    Fatima, Merium
    Hassan, Muhammad
    Sheikh, Ali Zafar
    Tahseen, Muhammad
    Sheikh, Umer Nisar
    Asghar, Kashif
    ONCOTARGETS AND THERAPY, 2025, 18 : 367 - 377
  • [35] Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease
    Antonio Macchiarulo
    Emidio Camaioni
    Roberto Nuti
    Roberto Pellicciari
    Amino Acids, 2009, 37 : 219 - 229
  • [36] Highlights at the gate of tryptophan catabolism: a review on the mechanisms of activation and regulation of indoleamine 2,3-dioxygenase (IDO), a novel target in cancer disease
    Macchiarulo, Antonio
    Camaioni, Emidio
    Nuti, Roberto
    Pellicciari, Roberto
    AMINO ACIDS, 2009, 37 (02) : 219 - 229
  • [37] Resveratrol suppresses tumor progression via the regulation of indoleamine 2,3-dioxygenase
    Noh, Kyung Tae
    Chae, Seung Hoon
    Chun, Sung Hak
    Jung, In Duk
    Kang, Hyun Kyu
    Park, Yeong-Min
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 431 (02) : 348 - 353
  • [38] Expression of indoleamine 2,3-dioxygenase in acute leukemic cells and the clinical significance
    Chen, Xiang-Li
    Guo, Jian-Min
    Zhang, Yin
    Niu, Xiao-Na
    Pei, Xiao-Hang
    Zhang, Wen-Hui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (05): : 8605 - 8609
  • [39] Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma
    Inaba, Tomoko
    Ino, Kazuhiko
    Kajiyama, Hiroaki
    Yamamoto, Eiko
    Shibata, Kiyosumi
    Nawa, Akihiro
    Nagasaka, Tetsuro
    Akimoto, Hidetoshi
    Takikawa, Osamu
    Kikkawa, Fumitaka
    GYNECOLOGIC ONCOLOGY, 2009, 115 (02) : 185 - 192
  • [40] Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor
    Song, Xiaotian
    Si, Qianqian
    Qi, Rui
    Liu, Weidan
    Li, Miao
    Guo, Mengyue
    Wei, Lin
    Yao, Zhiyan
    FRONTIERS IN IMMUNOLOGY, 2021, 12